Third Harmonic Bio Inc reports results for the quarter ended March 31 - Earnings Summary
I'm PortAI, I can summarize articles.
Third Harmonic Bio Inc reported a quarterly adjusted loss of 35 cents per share for the quarter ended March 31, compared to a loss of 20 cents per share in the same quarter last year. The reported revenue was zero, matching analyst expectations. The company incurred a quarterly loss of $15.83 million. Analysts have revised earnings estimates down by 4.9% over the last three months. The average analyst rating is "hold" with a median 12-month price target of $5.23. Shares rose 48.7% this quarter but are down 49.9% year-to-date.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments